Kansas City, MONCT07680244Now EnrollingIRB Ready

Epiretinal Membrane Clinical Trial in Kansas City, MO

Access cutting-edge epiretinal membrane treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.

Sponsored by Carl Zeiss Meditec-Dublin CoCe

Quick Self-Assessment

See if you qualify for this Kansas City location

Preparing your pre-screening questions…

Expert Care in Kansas City

Access epiretinal membrane specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related epiretinal membrane treatment provided free

Apply for This Kansas City Location

Check if you qualify for this epiretinal membrane clinical trial in Kansas City, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kansas City

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kansas City site if eligible
  4. 4Begin participation

About This Epiretinal Membrane Study in Kansas City

This study will measure how well PathFinder 1.0 detects retinal abnormalities on macular cube OCT B-scans by assessing its sensitivity and specificity.

Sponsor: Carl Zeiss Meditec-Dublin CoCe

Who Can Participate

Inclusion Criteria

Able and willing to make the required study visits.
Able and willing to give written informed consent and follow study instructions.
Able and willing to complete ophthalmic imaging.
Adults 18 years of age or older. The subject population will be comprised of two groups (all categories below pertain to the central 6x6 mm macula area): Group A 1\. Subjects with absence of macular abnormalities Group B
Subjects with Disruption of the vitreoretinal interface (VRI)
Subjects with Intraretinal hyporeflective space (IRHS)
Subjects with Subretinal hyporeflective space (SRHS)
Subjects with IS/OS (Ellipsoid Zone) disruption
Subjects with Retinal Pigment Epithelium (RPE) elevation
Subjects with Retinal Pigment Epithelium (RPE) atrophy
Other abnormalities

Exclusion Criteria

Inability to undergo the required tests.
Unable to give consent or follow study instructions.
Inability to fixate that precludes obtaining acceptable macula scans in the study eye.
Visudyne (verteporfin) injection within the last 48 hours in the study eye.
Pilocarpine or Vuity use within the last 24 hours in the study eye.
Dense media opacity precluding adequate visualization of the retina in the study eye.
Vitreous floaters that preclude obtaining acceptable scans in the study eye.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kansas City?

Yes, this clinical trial (NCT07680244) has an active research site in Kansas City, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Epiretinal Membrane Treatment Options in Kansas City, MO

If you're searching for epiretinal membrane treatment options in Kansas City, MO, this clinical trial (NCT07680244) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epiretinal membrane specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all epiretinal membrane clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Kansas City, MO

See all essential tremor clinical trials recruiting in Kansas City — not just this study.

Browse Essential Tremor Trials in Kansas City →

Browse More Trials by Condition

Essential Tremor TrialsRheumatoid Arthritis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Kansas City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kansas City, MO